Global Cell and Gene Therapy Market Report, History and Forecast 2016-2027, Breakdown Data by Companies, Key Regions, Types and Application
SKU ID : QYR-18672502 | Publishing Date : 01-Jul-2021 | No. of pages : 115
Detailed TOC of Global Cell and Gene Therapy Market Report, History and Forecast 2016-2027, Breakdown Data by Companies, Key Regions, Types and Application
1 Market Overview of Cell and Gene Therapy1.1 Cell and Gene Therapy Market Overview
1.1.1 Cell and Gene Therapy Product Scope
1.1.2 Cell and Gene Therapy Market Status and Outlook
1.2 Global Cell and Gene Therapy Market Size Overview by Region 2016 VS 2021VS 2027
1.3 Global Cell and Gene Therapy Market Size by Region (2016-2027)
1.4 Global Cell and Gene Therapy Historic Market Size by Region (2016-2021)
1.5 Global Cell and Gene Therapy Market Size Forecast by Region (2022-2027)
1.6 Key Regions, Cell and Gene Therapy Market Size (2016-2027)
1.6.1 North America Cell and Gene Therapy Market Size (2016-2027)
1.6.2 Europe Cell and Gene Therapy Market Size (2016-2027)
1.6.3 Asia-Pacific Cell and Gene Therapy Market Size (2016-2027)
1.6.4 Latin America Cell and Gene Therapy Market Size (2016-2027)
1.6.5 Middle East & Africa Cell and Gene Therapy Market Size (2016-2027)
2 Cell and Gene Therapy Market Overview by Type
2.1 Global Cell and Gene Therapy Market Size by Type: 2016 VS 2021 VS 2027
2.2 Global Cell and Gene Therapy Historic Market Size by Type (2016-2021)
2.3 Global Cell and Gene Therapy Forecasted Market Size by Type (2022-2027)
2.4 Rare Diseases
2.5 Oncology
2.6 Hematology
2.7 Cardiovascular
2.8 Ophthalmology
2.9 Neurology
2.10 Other Therapeutic Classes
3 Cell and Gene Therapy Market Overview by Application
3.1 Global Cell and Gene Therapy Market Size by Application: 2016 VS 2021 VS 2027
3.2 Global Cell and Gene Therapy Historic Market Size by Application (2016-2021)
3.3 Global Cell and Gene Therapy Forecasted Market Size by Application (2022-2027)
3.4 Pharmaceutical and Biotechnology Companies
3.5 Research and Academic Institutions
3.6 Contract Research Organizations (CROs)
3.7 Hospital
3.8 Others
4 Cell and Gene Therapy Competition Analysis by Players
4.1 Global Cell and Gene Therapy Market Size by Players (2016-2021)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cell and Gene Therapy as of 2020)
4.3 Date of Key Players Enter into Cell and Gene Therapy Market
4.4 Global Top Players Cell and Gene Therapy Headquarters and Area Served
4.5 Key Players Cell and Gene Therapy Product Solution and Service
4.6 Competitive Status
4.6.1 Cell and Gene Therapy Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles and Key Data
5.1 Amgen Inc.
5.1.1 Amgen Inc. Profile
5.1.2 Amgen Inc. Main Business
5.1.3 Amgen Inc. Cell and Gene Therapy Products, Services and Solutions
5.1.4 Amgen Inc. Cell and Gene Therapy Revenue (US$ Million) & (2016-2021)
5.1.5 Amgen Inc. Recent Developments
5.2 bluebird bio, Inc.
5.2.1 bluebird bio, Inc. Profile
5.2.2 bluebird bio, Inc. Main Business
5.2.3 bluebird bio, Inc. Cell and Gene Therapy Products, Services and Solutions
5.2.4 bluebird bio, Inc. Cell and Gene Therapy Revenue (US$ Million) & (2016-2021)
5.2.5 bluebird bio, Inc. Recent Developments
5.3 Dendreon Pharmaceuticals LLC.
5.5.1 Dendreon Pharmaceuticals LLC. Profile
5.3.2 Dendreon Pharmaceuticals LLC. Main Business
5.3.3 Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Products, Services and Solutions
5.3.4 Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Revenue (US$ Million) & (2016-2021)
5.3.5 Fibrocell Science, Inc. Recent Developments
5.4 Fibrocell Science, Inc.
5.4.1 Fibrocell Science, Inc. Profile
5.4.2 Fibrocell Science, Inc. Main Business
5.4.3 Fibrocell Science, Inc. Cell and Gene Therapy Products, Services and Solutions
5.4.4 Fibrocell Science, Inc. Cell and Gene Therapy Revenue (US$ Million) & (2016-2021)
5.4.5 Fibrocell Science, Inc. Recent Developments
5.5 Human Stem Cells Institute
5.5.1 Human Stem Cells Institute Profile
5.5.2 Human Stem Cells Institute Main Business
5.5.3 Human Stem Cells Institute Cell and Gene Therapy Products, Services and Solutions
5.5.4 Human Stem Cells Institute Cell and Gene Therapy Revenue (US$ Million) & (2016-2021)
5.5.5 Human Stem Cells Institute Recent Developments
5.6 Kite Pharma, Inc.
5.6.1 Kite Pharma, Inc. Profile
5.6.2 Kite Pharma, Inc. Main Business
5.6.3 Kite Pharma, Inc. Cell and Gene Therapy Products, Services and Solutions
5.6.4 Kite Pharma, Inc. Cell and Gene Therapy Revenue (US$ Million) & (2016-2021)
5.6.5 Kite Pharma, Inc. Recent Developments
5.7 Kolon TissueGene, Inc.
5.7.1 Kolon TissueGene, Inc. Profile
5.7.2 Kolon TissueGene, Inc. Main Business
5.7.3 Kolon TissueGene, Inc. Cell and Gene Therapy Products, Services and Solutions
5.7.4 Kolon TissueGene, Inc. Cell and Gene Therapy Revenue (US$ Million) & (2016-2021)
5.7.5 Kolon TissueGene, Inc. Recent Developments
5.8 Novartis AG
5.8.1 Novartis AG Profile
5.8.2 Novartis AG Main Business
5.8.3 Novartis AG Cell and Gene Therapy Products, Services and Solutions
5.8.4 Novartis AG Cell and Gene Therapy Revenue (US$ Million) & (2016-2021)
5.8.5 Novartis AG Recent Developments
5.9 Orchard Therapeutics plc.
5.9.1 Orchard Therapeutics plc. Profile
5.9.2 Orchard Therapeutics plc. Main Business
5.9.3 Orchard Therapeutics plc. Cell and Gene Therapy Products, Services and Solutions
5.9.4 Orchard Therapeutics plc. Cell and Gene Therapy Revenue (US$ Million) & (2016-2021)
5.9.5 Orchard Therapeutics plc. Recent Developments
5.10 Organogenesis Holdings Inc.
5.10.1 Organogenesis Holdings Inc. Profile
5.10.2 Organogenesis Holdings Inc. Main Business
5.10.3 Organogenesis Holdings Inc. Cell and Gene Therapy Products, Services and Solutions
5.10.4 Organogenesis Holdings Inc. Cell and Gene Therapy Revenue (US$ Million) & (2016-2021)
5.10.5 Organogenesis Holdings Inc. Recent Developments
5.11 Pfizer, Inc.
5.11.1 Pfizer, Inc. Profile
5.11.2 Pfizer, Inc. Main Business
5.11.3 Pfizer, Inc. Cell and Gene Therapy Products, Services and Solutions
5.11.4 Pfizer, Inc. Cell and Gene Therapy Revenue (US$ Million) & (2016-2021)
5.11.5 Pfizer, Inc. Recent Developments
5.12 RENOVA THERAPEUTICS
5.12.1 RENOVA THERAPEUTICS Profile
5.12.2 RENOVA THERAPEUTICS Main Business
5.12.3 RENOVA THERAPEUTICS Cell and Gene Therapy Products, Services and Solutions
5.12.4 RENOVA THERAPEUTICS Cell and Gene Therapy Revenue (US$ Million) & (2016-2021)
5.12.5 RENOVA THERAPEUTICS Recent Developments
5.13 Shanghai Sunway Biotech Co., Ltd.,
5.13.1 Shanghai Sunway Biotech Co., Ltd., Profile
5.13.2 Shanghai Sunway Biotech Co., Ltd., Main Business
5.13.3 Shanghai Sunway Biotech Co., Ltd., Cell and Gene Therapy Products, Services and Solutions
5.13.4 Shanghai Sunway Biotech Co., Ltd., Cell and Gene Therapy Revenue (US$ Million) & (2016-2021)
5.13.5 Shanghai Sunway Biotech Co., Ltd., Recent Developments
5.14 Sibiono GeneTech Co. Ltd.,
5.14.1 Sibiono GeneTech Co. Ltd., Profile
5.14.2 Sibiono GeneTech Co. Ltd., Main Business
5.14.3 Sibiono GeneTech Co. Ltd., Cell and Gene Therapy Products, Services and Solutions
5.14.4 Sibiono GeneTech Co. Ltd., Cell and Gene Therapy Revenue (US$ Million) & (2016-2021)
5.14.5 Sibiono GeneTech Co. Ltd., Recent Developments
5.15 Spark Therapeutics, Inc.
5.15.1 Spark Therapeutics, Inc. Profile
5.15.2 Spark Therapeutics, Inc. Main Business
5.15.3 Spark Therapeutics, Inc. Cell and Gene Therapy Products, Services and Solutions
5.15.4 Spark Therapeutics, Inc. Cell and Gene Therapy Revenue (US$ Million) & (2016-2021)
5.15.5 Spark Therapeutics, Inc. Recent Developments
5.16 Vericel Corporation
5.16.1 Vericel Corporation Profile
5.16.2 Vericel Corporation Main Business
5.16.3 Vericel Corporation Cell and Gene Therapy Products, Services and Solutions
5.16.4 Vericel Corporation Cell and Gene Therapy Revenue (US$ Million) & (2016-2021)
5.16.5 Vericel Corporation Recent Developments
5.17 ViroMed Co., Ltd.
5.17.1 ViroMed Co., Ltd. Profile
5.17.2 ViroMed Co., Ltd. Main Business
5.17.3 ViroMed Co., Ltd. Cell and Gene Therapy Products, Services and Solutions
5.17.4 ViroMed Co., Ltd. Cell and Gene Therapy Revenue (US$ Million) & (2016-2021)
5.17.5 ViroMed Co., Ltd. Recent Developments
6 North America
6.1 North America Cell and Gene Therapy Market Size by Country (2016-2027)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Cell and Gene Therapy Market Size by Country (2016-2027)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Cell and Gene Therapy Market Size by Region (2016-2027)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Cell and Gene Therapy Market Size by Country (2016-2027)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Cell and Gene Therapy Market Size by Country (2016-2027)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Cell and Gene Therapy Market Dynamics
11.1 Cell and Gene Therapy Industry Trends
11.2 Cell and Gene Therapy Market Drivers
11.3 Cell and Gene Therapy Market Challenges
11.4 Cell and Gene Therapy Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
List of Figures, Tables and Charts Available in Global Cell and Gene Therapy Market Report, History and Forecast 2016-2027, Breakdown Data by Companies, Key Regions, Types and Application
List of TablesTable 1. Global Market Cell and Gene Therapy Market Size (US$ Million) Comparison by Region 2016 VS 2021 VS 2027
Table 2. Global Cell and Gene Therapy Market Size by Region (2016-2021) & (US$ Million)
Table 3. Global Cell and Gene Therapy Market Size Share by Region (2016-2021)
Table 4. Global Cell and Gene Therapy Forecasted Market Size by Region (2022-2027) & (US$ Million)
Table 5. Global Cell and Gene Therapy Forecasted Market Size Share by Region (2022-2027)
Table 6. Global Cell and Gene Therapy Market Size (US$ Million) by Type: 2016 VS 2021 VS 2027
Table 7. Global Cell and Gene Therapy Market Size by Type (2016-2021) & (US$ Million)
Table 8. Global Cell and Gene Therapy Revenue Market Share by Type (2016-2021)
Table 9. Global Cell and Gene Therapy Forecasted Market Size by Type (2022-2027) & (US$ Million)
Table 10. Global Cell and Gene Therapy Revenue Market Share by Type (2022-2027)
Table 11. Global Cell and Gene Therapy Market Size (US$ Million) by Application: 2016 VS 2021 VS 2027
Table 12. Global Cell and Gene Therapy Market Size by Application (2016-2021) & (US$ Million)
Table 13. Global Cell and Gene Therapy Revenue Market Share by Application (2016-2021)
Table 14. Global Cell and Gene Therapy Forecasted Market Size by Application (2022-2027) & (US$ Million)
Table 15. Global Cell and Gene Therapy Revenue Market Share by Application (2022-2027)
Table 16. Global Cell and Gene Therapy Revenue (US$ Million) by Players (2016-2021)
Table 17. Global Cell and Gene Therapy Revenue Market Share by Players (2016-2021)
Table 18. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cell and Gene Therapy as of 2020)
Table 19. Date of Key Manufacturers Enter into Cell and Gene Therapy Market
Table 20. Global Cell and Gene Therapy Top Players Headquarters and Area Served
Table 21. Cell and Gene Therapy Product Solution and Service
Table 22. Global Cell and Gene Therapy Players Market Concentration Ratio (CR5 and HHI)
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Amgen Inc. Basic Information List
Table 25. Amgen Inc. Description and Business Overview
Table 26. Amgen Inc. Cell and Gene Therapy Products, Services and Solutions
Table 27. Revenue (US$ Million) in Cell and Gene Therapy Business of Amgen Inc. (2016-2021)
Table 28. Amgen Inc. Recent Developments
Table 29. bluebird bio, Inc. Basic Information List
Table 30. bluebird bio, Inc. Description and Business Overview
Table 31. bluebird bio, Inc. Cell and Gene Therapy Products, Services and Solutions
Table 32. Revenue (US$ Million) in Cell and Gene Therapy Business of bluebird bio, Inc. (2016-2021)
Table 33. bluebird bio, Inc. Recent Developments
Table 34. Dendreon Pharmaceuticals LLC. Basic Information List
Table 35. Dendreon Pharmaceuticals LLC. Description and Business Overview
Table 36. Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Products, Services and Solutions
Table 37. Revenue (US$ Million) in Cell and Gene Therapy Business of Dendreon Pharmaceuticals LLC. (2016-2021)
Table 38. Dendreon Pharmaceuticals LLC. Recent Developments
Table 39. Fibrocell Science, Inc. Basic Information List
Table 40. Fibrocell Science, Inc. Description and Business Overview
Table 41. Fibrocell Science, Inc. Cell and Gene Therapy Products, Services and Solutions
Table 42. Revenue (US$ Million) in Cell and Gene Therapy Business of Fibrocell Science, Inc. (2016-2021)
Table 43. Fibrocell Science, Inc. Recent Developments
Table 44. Human Stem Cells Institute Basic Information List
Table 45. Human Stem Cells Institute Description and Business Overview
Table 46. Human Stem Cells Institute Cell and Gene Therapy Products, Services and Solutions
Table 47. Revenue (US$ Million) in Cell and Gene Therapy Business of Human Stem Cells Institute (2016-2021)
Table 48. Human Stem Cells Institute Recent Developments
Table 49. Kite Pharma, Inc. Basic Information List
Table 50. Kite Pharma, Inc. Description and Business Overview
Table 51. Kite Pharma, Inc. Cell and Gene Therapy Products, Services and Solutions
Table 52. Revenue (US$ Million) in Cell and Gene Therapy Business of Kite Pharma, Inc. (2016-2021)
Table 53. Kite Pharma, Inc. Recent Developments
Table 54. Kolon TissueGene, Inc. Basic Information List
Table 55. Kolon TissueGene, Inc. Description and Business Overview
Table 56. Kolon TissueGene, Inc. Cell and Gene Therapy Products, Services and Solutions
Table 57. Revenue (US$ Million) in Cell and Gene Therapy Business of Kolon TissueGene, Inc. (2016-2021)
Table 58. Kolon TissueGene, Inc. Recent Developments
Table 59. Novartis AG Basic Information List
Table 60. Novartis AG Description and Business Overview
Table 61. Novartis AG Cell and Gene Therapy Products, Services and Solutions
Table 62. Revenue (US$ Million) in Cell and Gene Therapy Business of Novartis AG (2016-2021)
Table 63. Novartis AG Recent Developments
Table 64. Orchard Therapeutics plc. Basic Information List
Table 65. Orchard Therapeutics plc. Description and Business Overview
Table 66. Orchard Therapeutics plc. Cell and Gene Therapy Products, Services and Solutions
Table 67. Revenue (US$ Million) in Cell and Gene Therapy Business of Orchard Therapeutics plc. (2016-2021)
Table 68. Orchard Therapeutics plc. Recent Developments
Table 69. Organogenesis Holdings Inc. Basic Information List
Table 70. Organogenesis Holdings Inc. Description and Business Overview
Table 71. Organogenesis Holdings Inc. Cell and Gene Therapy Products, Services and Solutions
Table 72. Revenue (US$ Million) in Cell and Gene Therapy Business of Organogenesis Holdings Inc. (2016-2021)
Table 73. Organogenesis Holdings Inc. Recent Developments
Table 74. Pfizer, Inc. Basic Information List
Table 75. Pfizer, Inc. Description and Business Overview
Table 76. Pfizer, Inc. Cell and Gene Therapy Products, Services and Solutions
Table 77. Revenue (US$ Million) in Cell and Gene Therapy Business of Pfizer, Inc. (2016-2021)
Table 78. Pfizer, Inc. Recent Developments
Table 79. RENOVA THERAPEUTICS Basic Information List
Table 80. RENOVA THERAPEUTICS Description and Business Overview
Table 81. RENOVA THERAPEUTICS Cell and Gene Therapy Products, Services and Solutions
Table 82. Revenue (US$ Million) in Cell and Gene Therapy Business of RENOVA THERAPEUTICS (2016-2021)
Table 83. RENOVA THERAPEUTICS Recent Developments
Table 84. Shanghai Sunway Biotech Co., Ltd., Basic Information List
Table 85. Shanghai Sunway Biotech Co., Ltd., Description and Business Overview
Table 86. Shanghai Sunway Biotech Co., Ltd., Cell and Gene Therapy Products, Services and Solutions
Table 87. Revenue (US$ Million) in Cell and Gene Therapy Business of Shanghai Sunway Biotech Co., Ltd., (2016-2021)
Table 88. Shanghai Sunway Biotech Co., Ltd., Recent Developments
Table 89. Sibiono GeneTech Co. Ltd., Basic Information List
Table 90. Sibiono GeneTech Co. Ltd., Description and Business Overview
Table 91. Sibiono GeneTech Co. Ltd., Cell and Gene Therapy Products, Services and Solutions
Table 92. Revenue (US$ Million) in Cell and Gene Therapy Business of Sibiono GeneTech Co. Ltd., (2016-2021)
Table 93. Sibiono GeneTech Co. Ltd., Recent Developments
Table 94. Spark Therapeutics, Inc. Basic Information List
Table 95. Spark Therapeutics, Inc. Description and Business Overview
Table 96. Spark Therapeutics, Inc. Cell and Gene Therapy Products, Services and Solutions
Table 97. Revenue (US$ Million) in Cell and Gene Therapy Business of Spark Therapeutics, Inc. (2016-2021)
Table 98. Spark Therapeutics, Inc. Recent Developments
Table 99. Vericel Corporation Basic Information List
Table 100. Vericel Corporation Description and Business Overview
Table 101. Vericel Corporation Cell and Gene Therapy Products, Services and Solutions
Table 102. Revenue (US$ Million) in Cell and Gene Therapy Business of Vericel Corporation (2016-2021)
Table 103. Vericel Corporation Recent Developments
Table 104. ViroMed Co., Ltd. Basic Information List
Table 105. ViroMed Co., Ltd. Description and Business Overview
Table 106. ViroMed Co., Ltd. Cell and Gene Therapy Products, Services and Solutions
Table 107. Revenue (US$ Million) in Cell and Gene Therapy Business of ViroMed Co., Ltd. (2016-2021)
Table 108. ViroMed Co., Ltd. Recent Developments
Table 109. North America Cell and Gene Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 110. North America Cell and Gene Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 111. Europe Cell and Gene Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 112. Europe Cell and Gene Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 113. Asia-Pacific Cell and Gene Therapy Market Size by Region (2016-2021) & (US$ Million)
Table 114. Asia-Pacific Cell and Gene Therapy Market Size by Region (2022-2027) & (US$ Million)
Table 115. Asia-Pacific Cell and Gene Therapy Market Share by Region (2016-2021)
Table 116. Asia-Pacific Cell and Gene Therapy Market Share by Region (2022-2027)
Table 117. Latin America Cell and Gene Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 118. Latin America Cell and Gene Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 119. Middle East & Africa Cell and Gene Therapy Market Size by Players (2016-2021) & (US$ Million)
Table 120. Middle East & Africa Cell and Gene Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 121. Cell and Gene Therapy Market Trends
Table 122. Cell and Gene Therapy Market Drivers
Table 123. Cell and Gene Therapy Market Challenges
Table 124. Cell and Gene Therapy Market Restraints
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cell and Gene Therapy Market Size Year-over-Year 2016-2027 & (US$ Million)
Figure 2. Global Cell and Gene Therapy Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 3. Global Cell and Gene Therapy Market Share by Regions: 2021 VS 2027
Figure 4. Global Cell and Gene Therapy Forecasted Market Size Share by Region (2022-2027)
Figure 5. North America Cell and Gene Therapy Market Size (US$ Million) Growth Rate (2016-2027)
Figure 6. Europe Cell and Gene Therapy Market Size (US$ Million) and Growth Rate (2016-2027)
Figure 7. Asia-Pacific Cell and Gene Therapy Market Size (US$ Million) and Growth Rate (2016-2027)
Figure 8. Latin America Cell and Gene Therapy Market Size (US$ Million) and Growth Rate (2016-2027)
Figure 9. Middle East & Africa Cell and Gene Therapy Market Size (US$ Million) and Growth Rate (2016-2027)
Figure 10. Global Cell and Gene Therapy Market Size Share by Type in 2021 & 2027
Figure 11. Rare Diseases Market Size (US$ Million) YoY Growth (2016-2027)
Figure 12. Oncology Market Size (US$ Million) YoY Growth (2016-2027)
Figure 13. Hematology Market Size (US$ Million) YoY Growth (2016-2027)
Figure 14. Cardiovascular Market Size (US$ Million) YoY Growth (2016-2027)
Figure 15. Ophthalmology Market Size (US$ Million) YoY Growth (2016-2027)
Figure 16. Neurology Market Size (US$ Million) YoY Growth (2016-2027)
Figure 17. Global Cell and Gene Therapy Market Size Share by Application in 2021 & 2027
Figure 18. Pharmaceutical and Biotechnology Companies Market Size (US$ Million) YoY Growth (2016-2027)
Figure 19. Research and Academic Institutions Market Size (US$ Million) YoY Growth (2016-2027)
Figure 20. Contract Research Organizations (CROs) Market Size (US$ Million) YoY Growth (2016-2027)
Figure 21. Hospital Market Size (US$ Million) YoY Growth (2016-2027)
Figure 22. Others Market Size (US$ Million) YoY Growth (2016-2027)
Figure 23. Cell and Gene Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 24. Global Top 5 and Top 10 Players Cell and Gene Therapy Market Share in 2020
Figure 25. North America Cell and Gene Therapy Market Share by Country (2016-2027)
Figure 26. United States Cell and Gene Therapy Market Size (2016-2027) & (US$ Million)
Figure 27. Canada Cell and Gene Therapy Market Size (2016-2027) & (US$ Million)
Figure 28. Germany Cell and Gene Therapy Market Size (2016-2027) & (US$ Million)
Figure 29. France Cell and Gene Therapy Market Size (2016-2027) & (US$ Million)
Figure 30. U.K. Cell and Gene Therapy Market Size (2016-2027) & (US$ Million)
Figure 31. Italy Cell and Gene Therapy Market Size (2016-2027) & (US$ Million)
Figure 32. Russia Cell and Gene Therapy Market Size (2016-2027) & (US$ Million)
Figure 33. Nordic Cell and Gene Therapy Market Size (2016-2027) & (US$ Million)
Figure 34. Rest of Europe Cell and Gene Therapy Market Size (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Cell and Gene Therapy Market Share by Region (2016-2027)
Figure 36. China Cell and Gene Therapy Market Size (2016-2027) & (US$ Million)
Figure 37. Japan Cell and Gene Therapy Market Size (2016-2027) & (US$ Million)
Figure 38. South Korea Cell and Gene Therapy Market Size (2016-2027) & (US$ Million)
Figure 39. Southeast Asia Cell and Gene Therapy Market Size (2016-2027) & (US$ Million)
Figure 40. India Cell and Gene Therapy Market Size (2016-2027) & (US$ Million)
Figure 41. Australia Cell and Gene Therapy Market Size (2016-2027) & (US$ Million)
Figure 42. Rest of Asia-Pacific Cell and Gene Therapy Market Size (2016-2027) & (US$ Million)
Figure 43. Latin America Cell and Gene Therapy Market Share by Country (2016-2027)
Figure 44. Mexico Cell and Gene Therapy Market Size (2016-2027) & (US$ Million)
Figure 45. Brazil Cell and Gene Therapy Market Size (2016-2027) & (US$ Million)
Figure 46. Rest of Latin America Cell and Gene Therapy Market Size (2016-2027) & (US$ Million)
Figure 47. Middle East & Africa Cell and Gene Therapy Market Share by Country (2016-2027)
Figure 48. Turkey Cell and Gene Therapy Market Size (2016-2027) & (US$ Million)
Figure 49. Saudi Arabia Cell and Gene Therapy Market Size (2016-2027) & (US$ Million)
Figure 50. UAE Cell and Gene Therapy Market Size (2016-2027) & (US$ Million)
Figure 51. Rest of Middle East & Africa Cell and Gene Therapy Market Size (2016-2027) & (US$ Million)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Keyplayers in Global Cell and Gene Therapy Market Report, History and Forecast 2016-2027, Breakdown Data by Companies, Key Regions, Types and Application
Amgen Inc.bluebird bio, Inc.
Dendreon Pharmaceuticals LLC.
Fibrocell Science, Inc.
Human Stem Cells Institute
Kite Pharma, Inc.
Kolon TissueGene, Inc.
Novartis AG
Orchard Therapeutics plc.
Organogenesis Holdings Inc.
Pfizer, Inc.
RENOVA THERAPEUTICS
Shanghai Sunway Biotech Co., Ltd.,
Sibiono GeneTech Co. Ltd.,
Spark Therapeutics, Inc.
Vericel Corporation
ViroMed Co., Ltd.